Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.
Sanger Sequencing Market Growth Analysis: How Will Revenue Expand During The Forecast Period?
The market for Sanger sequencing has experienced swift expansion lately, projecting a rise from $3.29 billion in 2025 to $3.85 billion in 2026, driven by a compound annual growth rate (CAGR) of 17.1%. Factors contributing to this historical growth trajectory include the initial recognition of Sanger sequencing as the definitive method, augmented investment in academic and governmental genomics research, a surge in genetic disorder diagnostic applications, broadened utilization within forensic science, and escalating research and development initiatives in the pharmaceutical sector.
The sanger sequencing market is projected for significant expansion in the upcoming years, reaching an estimated $7.13 billion by 2030. This impressive growth trajectory, with a compound annual growth rate (CAGR) of 16.7%, is fueled by several key factors. These include the persistent requirement for confirmation alongside next-generation sequencing (NGS) technologies, the burgeoning field of personalized medicine, an escalating demand for affordable targeted sequencing solutions, the broadening scope of clinical diagnostics within developing economies, and a heightened level of cooperation between biotechnology companies and academic institutions. During this projected timeframe, several prominent trends are anticipated: sanger sequencing will continue its role in validating NGS outcomes, a consistent need for targeted gene sequencing in diagnostic settings will persist, its application in biomarker discovery and cancer research will expand, specialized laboratories will see increased outsourcing of sequencing services, and its established use in forensic and reproductive health testing will be maintained.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13925&type=smp
Sanger Sequencing Market Development Factors: Which Trends Are Supporting Demand?
The escalating prevalence of genetic disorders is anticipated to fuel the expansion of the Sanger sequencing market. These inherited conditions, characterized by alterations or defects in an individual’s DNA, which comprises the genetic blueprint, necessitate diagnostic tools like Sanger sequencing. This method meticulously deciphers the precise sequence of nucleotide bases within a particular DNA segment, thereby aiding in the identification of genetic abnormalities. Illustratively, as reported by the National Health Service in August 2024, the United Kingdom had an estimated 2,300 individuals diagnosed with thalassaemia in the current year, with approximately 800 of these cases involving the severe manifestation requiring ongoing blood transfusions. Consequently, the increasing incidence of genetic illnesses directly correlates with the projected growth trajectory of the Sanger sequencing market.
Sanger Sequencing Market Segmentation And Category Breakdown
The sanger sequencing market covered in this report is segmented –
1) By Sequencing: Shotgun Sequencing, Targeted Gene Sequencing, Other Sequencing
2) By Laboratory: Wet Labs, Dry Labs
3) By Research: In-House, Outsourced
4) By Application: Diagnostics, Biomarkers And Cancer, Reproductive Health, Personalized Medicine, Forensics, Other Applications
5) By End User: Academic, Government Research Institutes, Pharmaceutical Companies, Biotechnology Companies, Hospitals, Clinics
Subsegments:
1) By Shotgun Sequencing: Whole Genome Shotgun Sequencing, Metagenomic Shotgun Sequencing
2) By Targeted Gene Sequencing: Amplicon Sequencing, Exome Sequencing
3) By Other Sequencing: Nested PCR Sequencing, Capillary Electrophoresis Based Sanger Sequencing
Sanger Sequencing Market Transformation Trends: Which Innovations Are Driving Change?
To enhance service provision across the northern regions of the United Kingdom, key players within the sanger sequencing market are actively broadening their genomic laboratory infrastructures, thereby enabling accelerated sanger sequencing delivery. These advanced genomic laboratories serve as pivotal centers for genetic diagnostics and analytical pursuits, delving into gene and genome characteristics like structure, behavior, and hereditary patterns, frequently in service of diagnostic, investigative, and individualized healthcare objectives. As a case in point, in June 2023, Source Genomics, a prominent UK entity specializing in genomic solutions, announced the enlargement of its genomic laboratory capabilities into Northern England, a move poised to amplify its sanger sequencing service capacity and significantly shorten data processing durations. This strategic extension of laboratory operations towards the northern territories represents a substantial stride towards ensuring uniform availability of genomic services for research bodies throughout the nation, ultimately allowing a wider customer base to access superior sanger sequencing with improved response times.
Sanger Sequencing Market Competitive Analysis Of Major Industry Participants
Major companies operating in the sanger sequencing market are Hoffmann La Roche, Thermo Fisher Scientific Inc, Merck KGaA, Eurofins Scientific, Beckman Coulter, PerkinElmer Inc, LGC Limited, GenScript, Macrogen Inc, GENEWIZ Inc, Quintara Biosciences, CeMIA SA, Source BioScience, Microsynth AG, Fasteris SA, GenHunter Corporation, Nucleics Pty Ltd, SciGenom Labs Pvt Ltd, StarSEQ GmbH, GATC Biotech AG, Agilent Technologies, Azenta Life Sciences, CD Genomics, Novogene Sanger Services
Access The Complete Sanger Sequencing Market Report:
https://www.thebusinessresearchcompany.com/report/sanger-sequencing-global-market-report
Sanger Sequencing Market Global Footprint: Which Region Holds Market Leadership?
North Americawas the largest region in the sanger sequencing market in 2025. The regions covered in the sanger sequencing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
